ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Early Hypertransaminasemia in Kidney Transplant Recipient: Influence of Donor Type and Clinical Significance

E. Solà-Porta, M. Redondo-Pachón, S. Núñez-Delgado, C. Arias-Cabrales, M. Mir, A. Buxeda, C. Burballa, M. Crespo, J. Pascual, M. Pérez-Sáez

Nephrology, Hospital del Mar, Barcelona, Spain

Meeting: 2021 American Transplant Congress

Abstract number: 907

Keywords: Donors, non-heart-beating, Ischemia, Kidney transplantation, Liver

Topic: Clinical Science » Kidney » Kidney: Cardiovascular and Metabolic Complications

Session Information

Session Name: Kidney: Cardiovascular and Metabolic Complications

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: The increase in transaminases after kidney transplant (KT) is frequent. Although the cause is unknown, it has been associated with factors such as immunosuppression, infections and cross-talk between liver and kidney in ischemia-reperfusion situations. However, the influence of the type of donor has not been evaluated. We analyze the incidence, relevance and meaning of post-KT hypertransaminasemia.

*Methods: Retrospective study (2004-2018) to analyze the increase in serum AST/ALT during the first 3 months after KT in 119 consecutive KT recipients of deceased donors either brain death (DBD), controlled after cardiac death (cDCD) or uncontrolled after cardiac death (uDCD). All donors received induction with thymoglobulin and maintenance with tacrolimus and mycophenolate.

*Results: Comparing the donor groups, in the uDCD group (n=39) donors and recipients were younger, there were more first transplants and prolonged delayed graft function, although creatinine was similar at 3 months. There were no differences in liver disease history, cold ischemia time, or post-KT hypotension. There were no differences in thymoglobulin induction dose, and uDCD recipients presented lower levels of tacrolimus at one week post-KT. At 72 hours post-KT, 69.2/82.1% of uDCD recipients presented elevation of AST/ALT over the normal values (vs 22/29.3% DBD and 21.1/21.1% cDCD, p<0.001) and 30.8/56.4% presented an elevation of AST/ALT twice over the normal values (vs 6.8/12.1% DBD and 5/5% cDCD, p=0.024/<0.001). This elevation was resolved early, one moth after KT AST/ALT values in all groups were below normal limits (Figure). In the multivariate analysis, donor type was associated with hypertransaminasemia at 72 hours post-KT and, in the uDCD group, hypertransaminasemia was not associated with a prolonged delayed graft function (creatinine decrease> 15 days post-KT).

*Conclusions: Post-transplant hypertransaminasemia is frequent and is associated with the type of kidney donor. This finding is temporary and is not related to a prolonged delayed graft function.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Solà-Porta E, Redondo-Pachón M, Núñez-Delgado S, Arias-Cabrales C, Mir M, Buxeda A, Burballa C, Crespo M, Pascual J, Pérez-Sáez M. Early Hypertransaminasemia in Kidney Transplant Recipient: Influence of Donor Type and Clinical Significance [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/early-hypertransaminasemia-in-kidney-transplant-recipient-influence-of-donor-type-and-clinical-significance/. Accessed June 1, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences